Low dose regimens retain adequate efficacy in some areas, but this is not uniform.
PCR-NALFIA is a sensitive, specific and robust assay able to identify Plasmodium species with good accuracy.
The emergence of highly chloroquine (CQ) resistant P. vivax in Southeast Asia has created an urgent need for an improved understanding of the mechanisms of drug resistance in these parasites, the development of robust tools for defining the spread of resistance, and the discovery of new antimalarial agents.
Blood samples were collected in Gimpo city, Paju city, Yeoncheon County, Cheorwon County and Goseong County of high risk area in South Korea.
Clinical pattern/manifestations of severe P. vivax were described in children admitted at New Halfa Hospital in Sudan between September 2009-December 2011.
Reactive oxygen species produced from hemoglobin digestion and the host immune system could have adverse effects on malaria parasites.
In the group of infants with Plasmodium vivax malaria that was monitored by Imwong et al , most of the first recurrences were found to be caused by parasites that were genotypically similar to those that had given rise to the initial clinical symptoms.
In general, AL was effective and well tolerated in Jimma Zone, Ethiopia.
PCR amplification coupled with pyrosequencing was used to measure molecular markers that could be used to detect and differentiate Plasmodium falciparum and Plasmodium vivax in human blood samples.
We conducted this prospective study among 110 symptomatic Plasmodium vivax patients attending the Kasturba Hospital, Manipal, India, in order to evaluate their clinico-laboratory profile during July 2007–July 2009.